Scholarly Open Access Journals In Pharmacogenomics

Pharmacogenomics is the study of how genes affect a person's response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective and safe drugs and doses that will be adapted to a person's genetic makeup. Many drugs currently available are "one size fits all", but they don't work the same for everyone. It can be difficult to predict who will benefit from a drug, who will not respond at all, and who will experience negative side effects (called adverse drug reactions). Adverse drug reactions are a major cause of hospitalizations and deaths in the United States. Using the knowledge gained from the human genome project, researchers are learning how inherited differences in genes affect the body's response to drugs. These genetic differences will be used to predict whether a drug will work for a particular person and to help prevent adverse drug reactions. In pharmacogenomics, genomic information is used to study individual responses to drugs. When a gene variant is associated with a particular drug response in a patient, there is the potential for making clinical decisions based on genetics by adjusting the dosage or choosing a different drug, for example. Scientists assess gene variants affecting an individual's drug response the same way they assess gene variants associated with diseases: by identifying genetic loci associated with known drug responses, and then testing individuals whose response is unknown. Modern approaches include multigene analysis or whole-genome single nucleotide polymorphism (SNP) profiles, and these approaches are just coming into clinical use for drug discovery and development.

High Impact List of Articles

Conference Proceedings

Peripheral blood hematopoietic progenitor cells correlate with clinical outcome of trauma haemorrhagic shock
Manoj Kumar, Keshava Sharma, Arul Selvi, Sujata Mohanty, D N Rao and Sanjeev Bhoi
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Peripheral blood hematopoietic progenitor cells correlate with clinical outcome of trauma haemorrhagic shock
Manoj Kumar, Keshava Sharma, Arul Selvi, Sujata Mohanty, D N Rao and Sanjeev Bhoi
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Bioavailable metals following 3 extraction methods (BCR, Tessier and Protease K) in sediments from Huelva estuary (Southwestern Spain)
Daniel Rosado, Jose Usero and Jose Morillo
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Bioavailable metals following 3 extraction methods (BCR, Tessier and Protease K) in sediments from Huelva estuary (Southwestern Spain)
Daniel Rosado, Jose Usero and Jose Morillo
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Inflectra-our experience on immunogenicity (case series)
Rodica Olteanu, Alexandra Zota and Magda Constantin
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Inflectra-our experience on immunogenicity (case series)
Rodica Olteanu, Alexandra Zota and Magda Constantin
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Supplementary protection certificates (SPCs) in Europe â�?�? What is the â�?�?basic patentâ�?�? and what is the â�?�?productâ�?�??
Tom Carver
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Supplementary protection certificates (SPCs) in Europe â�?�? What is the â�?�?basic patentâ�?�? and what is the â�?�?productâ�?�??
Tom Carver
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Biosimilars market access and penetration in the Obama care era â�?�?Considerations for providers, payers, prescribers and patients
Gary C Cupit
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Biosimilars market access and penetration in the Obama care era â�?�?Considerations for providers, payers, prescribers and patients
Gary C Cupit
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine

Pharmaceutical Regulatory Affairs: Open Access